| Literature DB >> 29661032 |
Sarah Kneis1, Anja Wehrle2, Anne Ilaender3, Natalja Volegova-Neher4, Albert Gollhofer3, Hartmut Bertz1.
Abstract
PURPOSE: Although there is evidence that breast cancer patients benefit from exercising during treatment, exercising during radiotherapy and especially the effects on upper-limb dysfunctions have been infrequently assessed. Therefore, we primarily aimed to confirm our interventions' feasibility and secondarily aimed to affect upper-limb dysfunctions and fatigue.Entities:
Keywords: breast cancer; exercise therapy; fatigue; handheld vibration; postural balance; radiotherapy; range of motion; upper-limb dysfunction; vibration
Mesh:
Year: 2018 PMID: 29661032 PMCID: PMC6142090 DOI: 10.1177/1534735418766615
Source DB: PubMed Journal: Integr Cancer Ther ISSN: 1534-7354 Impact factor: 3.279
Patient Characteristics of Completers (n = 21).[a]
| IG (n = 11) | CG (n = 10)[ |
| |
|---|---|---|---|
| Age (years), median (min-max) | 52 (39-72) | 64 (48-79) |
|
| BMI (kg/m2), median (min-max) | 24.0 (20.9-28.8) | 26.7 (20.2-35.5) | .152 |
| Stage of breast cancer (n)[ | |||
| 0 | 2 | 0 | |
| I | 3 | 6 | |
| II (A/B) | 6 | 4 | |
| Surgery, n (%) | 11 (100) | 10 (100) | |
| Breast conserving | 10 (91) | 10 (100) | |
| Mastectomy | 1 (9) | 0 (0) | |
| Chemotherapy, n (%) | 5 (46) | 5 (50) | |
| Antibody therapy, n (%) | 1 (9) | 1 (10) | |
| Compliance (%), mean ± SD | 98 ± 5 | ||
Abbreviations: IG, intervention group; CG, control group; BMI, body mass index.
Significant results are highlighted in boldface P < .05.
No postintervention data were available for one patient.
According to UICC TNM staging system.
Outcome Parameters Pre (T0) and Post (T1) Intervention in the Intervention Group (IG, n = 11) and Control Group (CG, n = 10).[a]
| T0, Median (95% CI) | T1, Median (95% CI) | Median Difference[ | T1 − T0 | ||
|---|---|---|---|---|---|
| Range of shoulder motion | |||||
| Abduction (°) | IG | 165 (134 to 169) | 175 (148 to 180) | 11 (5 to 20) |
|
| CG | 160 (135 to 169) | 168 (139 to 178) | 5 (0 to 15) | .168 | |
|
| 1.000 | .557 | .132 | ||
| External rotation (°) | IG | 55 (80 to 63) | 60 (55 to 68) | 5 (0 to 10) |
|
| CG | 60 (47 to 64) | 52 (49 to 60) | −1 (−8 to 6) | .671 | |
|
| .654 | .720 | .051 | ||
| Hand-behind-back position (cm)[ | IG | 13.0 (10.2 to 15.3) | 10.0 (8.5 to 14.0) | −1.0 (−4.5 to 1.0) | .200 |
| CG | 14.5 (10.3 to 19.1) | 16.0 (11.8 to 18.8) | 0.5 (−0.5 to 2.0) | .282 | |
|
| .605 |
| .132 | ||
| Hand grip strength (kg) | IG | 26.2 (22.6 to 31.2) | 28.6 (24.4 to 32.3) | 1.6 (−0.6 to 3.1) | .050 |
| CG | 26.1 (23.7 to 29.4) | 26.6 (23.5 to 30.1) | 0.3 (−2.8 to 3.8) | .799 | |
|
| 1.000 | .654 | .426 | ||
| Vibration sense (scale 0-8) | IG | 7.0 (6.7 to 7.5) | 7.0 (6.4 to 7.6) | −0.13 (−0.5 to 0.3) | .469 |
| CG | 6.5 (5.4 to 7.3) | 5.4 (4.3 to 6.5) | −1.0 (−1.5 to −0.5) |
| |
|
| .132 | .060 |
| ||
| COF displacement | |||||
| Semitandem EO (mm) | IG | 471 (427 to 569) | 487 (433 to 542) | −12 (−65 to 44) | .594 |
| CG | 644 (542 to 845) | 565 (500 to 733) | −70 (−180 to 17) | .114 | |
|
|
|
| .251 | ||
| Semitandem EC (mm) | IG | 859 (726 to 997) | 805 (676 to 956) | −22 (−152 to 45) | .424 |
| CG | 1259 (1055 to 2009) | 1167 (984 to 1694) | −187 (−301 to −14) |
| |
|
|
|
|
| ||
| One-leg stance EO (mm) | IG | 1172 (1038 to 1595) | 1103 (931 to 1316) | −185 (−409 to 15) | .050 |
| CG | 1591 (956 to 2008) | 1382 (899 to 1644) | −207 (−412 to −4) |
| |
|
| .791 | .659 | .724 | ||
| Counter movement jump | |||||
| Jump height (cm) | IG | 22.3 (19.8 to 27.0) | 26.7 (21.4 to 28.3) | 1.6 (−0.1 to 3.2) | .050 |
| CG | 19.8 (15.8 to 26.1) | 19.4 (15.3 to 25.1) | −0.6 (−1.7 to 0.2) | .114 | |
|
| .387 | .990 |
| ||
| Pmax_jump (Watt/kg) | IG | 27.25 (22.00 to 29.49) | 27.92 (23.06 to 30.62) | 0.44 (−0.59 to 1.31) | .374 |
| CG | 22.02 (16.51 to 29.02) | 22.64 (17.79 to 26.55) | −0.04 (−1.81 to 1.28) | .878 | |
|
| .251 | .132 | .654 | ||
| Cardiorespiratory fitness | |||||
| VO2peak (L/min) | IG | 1.53 (1.25 to 1.65) | 1.40 (1.26 to 1.59) | −0.04 (−0.18 to 0.10) | .594 |
| CG | 1.49 (1.06 to 1.84) | 1.42 (1.06 to 1.85) | 0.02 (−0.11 to 0.12) | .859 | |
|
| .710 | .882 | .412 | ||
| Pmax_CPET (Watt) | IG | 100 (85 to 116) | 110 (90 to 124) | 7 (−3 to 15) | .138 |
| CG | 100 (64 to 125) | 88 (58 to 121) | −5 (−10 to 0) | .080 | |
|
| .456 | .112 |
| ||
| IAT (Watt) | IG | 70 (61 to 81) | 72 (61 to 87) | 2 (−5 to 7) | .721 |
| CG | 65 (50 to 94) | 72 (49 to 102) | 0 (−5 to 6) | 1.000 | |
|
| .780 | .717 | .965 | ||
| MFI20 dimensions of fatigue (score max. 20) | |||||
| General fatigue | IG | 13.0 (9.1 to 14.1) | 11.0 (7.1 to 13.3) | −2.0 (−3.0 to −1.0) |
|
| CG | 9.5 (6.5−12.3) | 12.0 (7.7 to 13.7) | 0.5 (−1.0 to 4.5) | .395 | |
|
| .132 | .557 |
| ||
| Physical fatigue | IG | 12.0 (9.1 to 14.2) | 10.0 (8.2 to 12.0) | −1.5 (−3.0 to 0.0) |
|
| CG | 8.0 (6.2 to 12.0) | 10.0 (8.2 to 11.9) | 1.5 (−1.5 to 3.0) | .292 | |
|
| .132 | .863 | .080 | ||
| Reduced activity | IG | 12.0 (8.9 to 13.5) | 11.0 (7.9 to 13.7) | −0.5 (−3.0 to 2.0) | .677 |
| CG | 10.5 (7.3 to 13.0) | 11.0 (8.0 to 12.6) | 0.0 (1.0 to 1.5) | .762 | |
|
| .756 | .973 | .670 | ||
| Reduced motivation | IG | 10.0 (7.7 to 11.2) | 8.0 (5.6 to 10.2) | −1.3 (−3.5 to 0.5) | .106 |
| CG | 7.5 (5.8 to 10.6) | 8.5 (7.2 to 11.6) | 1.5 (−0.5 to 3.0) | .073 | |
|
| .468 | .314 | .183 | ||
| Mental fatigue | IG | 11.0 (8.1 to 13.3) | 9.0 (6.6 to 10.5) | 4.2 (−0.0 to 16.7) |
|
| CG | 7.5 (5.5 to 10.3) | 8.0 (6.2 to 10.6) | 8.3 (−4.2 to 20.8) | .435 | |
|
| .099 | .973 | .086 | ||
Abbreviations: CI, confidence interval; COF, center of force; EO, eyes open; EC, eyes closed; Pmax_jump, maximum power output during countermovement jump; Pmax_CPET, maximum workload during cardiopulmonary exercise test; V̇O2peak, peak oxygen consumption; IAT, individual anaerobic threshold; MFI20, Multidimensional Fatigue Inventory.
Significant results are highlighted in boldface P < .05.
Prescribes the treatment effect by point estimation and 95% confidence interval of the Hodges-Lehmann’s median differences for paired groups.
Lower value means a higher range of motion.
Correlation Coefficients of Changes in Dimensions of Fatigue and Changes in Cardiorespiratory Fitness and Upper Limp Function.[a]
| Δ MFI20 Dimensions of Fatigue (Score Max. 20) | Δ Pmax_CPET (Watt) | Δ V̇O2peak (mL/min) | Δ IAT (Watt) | Δ Abduction (°) | Δ External Rotation (°) | Δ Hand Behind Back Position (cm) | Δ Hand Grip Strength (kg) | Δ Vibration Sense (Scale 0-8) |
|---|---|---|---|---|---|---|---|---|
| General fatigue | −.191 | .019 | .091 | −.311 | .019 | −.132 |
|
|
| Physical fatigue | −.289 | .251 | .409 | .020 | −.298 | .340 |
|
|
| Reduced activity | .076 | .329 | .014 | .130 | −.104 | −.115 | −.401 | −.355 |
| Reduced motivation | −.179 | .096 | .376 | −.077 | −.218 | .042 |
| −.101 |
| Mental fatigue |
| .250 | −.220 | .223 |
| .357 | −.012 | −.420 |
Abbreviations: Δ, T1 − T0; MFI20, Multidimensional Fatigue Inventory; Pmax_CPET, maximum workload during cardiopulmonary exercise test; V̇O2peak, peak oxygen consumption; IAT, individual anaerobic threshold.
Significant results are highlighted in boldface **P = .01. *P = .05.
Figure 1.Distribution of changes from T0 to T1 of (A) the MFI20 dimension of fatigue and (B) range of shoulder motion of affected upper limb in IG and CG. Box-and-whisker plots showing the lower quartile (25th percentile), median (50th percentile), upper quartile (75th percentile), and degree of dispersion as 95% confidence interval (95% CI). *Indicates a significant difference (*P < .05).
Figure 2.The scatterplot graphically represents the relationship between changes (Δ) of hand grip strength in kg (x-axis) versus changes (Δ) of 3 MFI20 dimensions of fatigue (y-axis) of IG and CG from T0 to T1. *Indicates a significant correlation (*P < .05).
Figure 3.Distribution of IG’s and CG’s vibration sense at T0 and T1. Y-axis presents graduating scale from 0 (no sensitivity) to 8 (highest sensitivity) of tuning fork. Box-and-whisker plots showing the lower quartile (25th percentile), median (50th percentile), the upper quartile (75th percentile), and degree of dispersion as 95% confidence interval (95% CI). *Indicates a significant difference (*P < .05).